Laminar Pharmaceuticals S.A. receives recommendation from the Independent Data Monitoring Committee to advance to the next stage of CLINGLIO, the phase 2b/3 Clinical Trial of LAM561 in combination with RT and TMZ for adults with newly diagnosed glioblastoma.

by Laminar Pharma

The independent data monitoring committee (IDMC) has recommended continuation of CLINGLIO without modification after its assessment of LAM561 interim efficacy in newly diagnosed Glioblastoma. This fol...

Read more

Rethinking clinical trial design for rare tumors

by VHIO

In an international study, they propose optimizing the design of clinical trials in rare tumors to speed up the study and approval of new drugs that will make it possible to respond to patients with t...

Read more

A European project led by IDIBAPS will test a diagnostic genomic test for breast cancer to improve patients' quality of life

by Fundació Clínic per a la Recerca Biomèdica

The DEFINITIVE project, led by IDIBAPS, will be conducted across 44 hospitals in a total of 7 European and associated countries to demonstrate that use of genomic test HER2DX® improves quality of lif...

Read more

Cambiamos el enfoque del abordaje de la obesidad: de contar quilos a buscar las causas del sobrepeso a través de la medicina personalizada

by Vall d’Hebron

La Unidad de Tratamiento Integral de la Obesidad Pediátrica ha recibido la acreditación de centro de excelencia de la Asociación Europea para el Estudio de la Obesidad, consolidando un modelo que o...

Read more

A European study in people with the participation of Clínic-IDIBAPS shows that treatment with the drug Abatacept reduces the risk of developing rheumatoid arthritis

by Fundació Clínic per a la Recerca Biomèdica

Published in the journal The Lancet, the study presents the results of Abatacept, a drug that modulates the activation of T cells, which play a key role in the progression of the disease.

Read more

Arranca EvaMobs, un proyecto europeo con participación del CNB-CSIC para el desarrollo de nuevos antivirales

by Centro Nacional de Biotecnología (CNB)

Este marco puede utilizarse para generar fácilmente moléculas específicas capaces de "atacar" e inactivar un virus. La tecnología puede utilizarse para crear moléculas que se adapten fácilmente ...

Read more

The first clinical trial of a gene therapy for Duchenne in children under 4 years old is initiated

by Fundació Sant Joan de Déu

A research team from the Institut de Recerca Sant Joan de Déu · SJD Barcelona Children’s Hospital is participating in an international clinical trial of a gene therapy for Duchenne muscular dystro...

Read more

Mikrobiomik presenta el primer 'antibiótico no antibiótico'

by Professional Newco

El medicamento biológico basado en microbiota intestinal MBK-01 trata a pacientes infectados con Clostridioides difficile, enfermedad que causa episodios muy graves de diarrea y que puede ser motivo ...

Read more

AbilityPharma Announces € 7 Million Financing Round to Advance Development of its Clinical Phase 2b Autophagy Inducer ABTL0812 in Metastatic Pancreatic Cancer

by Ability Pharma

AbilityPharma is currently completing an international Phase 2b clinical trial with its product ABTL0812 in patients with metastatic pancreatic cancer, a disease with a very low survival rate, with th...

Read more

La vitamina C, un aliado contra el cáncer de páncreas

by Fundación Jiménez Díaz

El hallazgo sugiere que la vitamina C podría ser una herramienta útil en el tratamiento del cáncer de páncreas, especialmente en casos de resistencia a la quimioterapia, y considerarse como una op...

Read more

Hospital Clínic-IDIBAPS researchers review adjuvant treatment with immunotherapy and vaccines for liver cancer

by Fundació Clínic per a la Recerca Biomèdica

The combination of surgery with adjuvant immunotherapy, after surgery, was shown to improve disease-free survival rates in the last IMbrave 050 phase III study

Read more

La 'mamografía 3D' reduce casi a la mitad la incidencia del cáncer de mama entre dos pruebas de cribado

by DiCYT - Agencia Iberoamericana para la Difusión de la Ciencia y la Tecnología

Un estudio clínico en el que han participado casi 40.000 mujeres revela la eficacia de la tomosíntesis mamaria para disminuir la tasa de carcinomas de intervalo

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un ensayo de microscopía dinámica del ...

by CSIC - Centro Superior de Investigaciones Científicas

La revista ‘Nature Protocols’ selecciona esta técnica como “pro...

Photos Stream